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Background: A key goal of palliative care is to improve the quality of life for patients and 
families living with serious illness.  However, valid, and reliable instruments are lacking to 
assess health-related quality of life (HRQOL) in pediatric palliative care.   
The objective of this systematic literature review is to update the previous review conducted by 
Coombes et al1. and to explore recent literature and to summarize the measurement properties of 
identified patient- and parent-reported HRQOL outcome measures for pediatric palliative care 
appropriate patients.   
Methods: A systematic review of the literature was conducted by searching EMBASE, Medline, 
and PsychInfo for recent assessment instruments that measure HRQOL in a life-limiting or life-
threatening illness.  The psychometric properties of identified measures were evaluated and 
summarized using COnsensus based Standards for the selection of health Measurement 
INstruments (COSMIN) guidelines.  
Results: After removing duplicates, 1,401 records were screened of which 19 manuscripts of 18 
studies were retained that supplied information about 12 HRQOL measures.  Measurement 
quality varied across studies.  Internal consistency and hypothesis testing for construct validity 
were most commonly assessed.  Most instruments lacked information on measurement 
invariance, responsiveness, and reliability. Information on measurement error was not available 
for any instrument.  No one instrument was identified as being appropriate for use in a non-
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disease specific pediatric palliative care population.  The PedsQL Epilepsy and QOLCE-55 
showed promise for use in children with epilepsy and palliative care needs.   
Conclusion: There was limited evidence on the psychometric properties of HRQOL instruments 
in a pediatric palliative care population. Future directions are identified including the need for  
additional research to test existing or develop new HRQOL outcome measures suitable for use in 
children and young people with serious and life-threatening illnesses.  Patient-reported outcome 
and experience measures are needed to assess and provide quality care for children and young 
people with life-limiting illnesses.  Generic measures that capture the daily burdens of living 
with life-limiting illness are needed to compare HRQOL across a variety of diseases and 
conditions. 
     Public health leadership skills, such as agenda setting, advocacy, and policy promotion, are 
needed to accelerate the development and implementation of pediatric palliative care HRQOL 
measures.   
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      An estimated 31.6 million children are living with life-limiting or life-threatening illness 
across the world.2  Over 400,000 children and young people in the United States 0-17 years of 
age are estimated to be living with serious illness in the United States.3  These numbers are 
expected to rise as medicine continues to advance and infants and children are living longer with 
serious illnesses.4  Serious illnesses throughout this paper are defined as life-limiting or life 
threatening conditions that adversely impact quality of life and function, and/or involve 
significant caregiver strain.5  Common pediatric serious illnesses include genetic/congenital 
disorders (e.g., cystic fibrosis), neurologic conditions (e.g. epilepsy), neuromuscular disorders 
(e.g., muscular dystrophy), solid tumor cancers and hematologic malignancies (e.g. leukemia), 
and other complex chronic conditions associated with high morbidity or mortality.4,6  Serious 
illness care often requires complicated management and intensive treatments and can place a 
heavy emotional, practical, and financial burden on patients, their families, and the health care 
system.5  
Pediatric palliative care is a specialized model of care for children and young people 
living with serious illness. Palliative care is a multidisciplinary support system that functions in 
conjunction with primary and other specialty care and can be delivered along with disease-
directed treatments.7 The goal of palliative care is to promote quality of life and reduce suffering 
by providing symptom relief and psychosocial and decision support for patients and their 
families. Unlike hospice, which is focused on the last few months of life, palliative care is 
appropriate across the disease trajectory starting from time of diagnosis. The fundamental goal of 




Health-Related Quality of Life 
The World Health Organization defines health as a combination of physical, mental, and 
social well-being and quality of life as an “individual’s perception of their position in life in the 
context of the culture and value systems in which they live and in relation to their goals, 
expectations, standards, and concerns.” 8  The impact that a person’s health has on his or her 
quality of life is known as health-related quality of life (HRQOL) and has been identified as a 
national public health priority.9  Measuring HRQOL can help assess the impact of social 
determinants of health, chronic disease, and clinical and public health interventions.  For the past 
30 years, improving HRQOL has been included as a fundamental component of the nationwide 
Healthy People 2000, 2010, and 2020 initiatives led by the U.S. Department of Health and 
Human Services.10  Self-reported HRQOL questions have been incorporated into many of the 
CDC’s surveillance surveys, such as the Behavioral Risk Factor Surveillance System (BRFSS) 
and the National Health and Nutrition Examination Survey (NHANES).10,11  Assessing 
population-level HRQOL can help public health officials and policy makers identify the groups 
and areas most in need of HRQOL interventions.  
Measuring Health-Related Quality-of-Life in Pediatric Palliative Care  
A clear understanding of a patient’s HRQOL can lead to identification of physical, 
psychological, and/or social problems that could be causing distress and may require 
intervention.12  Measures of health-related quality of life (HRQOL) should be subjective and 
multidimensional, and should minimally include physical, psychological, and social dimensions 
of health.13  Given that improving quality of life is also one of the main tenets of palliative care, 
psychometrically sound measurement tools are needed to assess health-related quality-of-life 
(HRQOL) accurately in a seriously ill population. Regular assessment and intervention upon 
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identified HRQOL concerns, can improve satisfaction with care, psychosocial and activity-
related issues, communication, and clinical decision-making in pediatric populations.14  Routine 
clinical assessment of patient reported outcome measures of HRQOL have been shown to 
improve communication between patients and their health care providers in adult populations by 
facilitating conversations about psychosocial functioning and other HRQOL issues.15  Studies 
have shown that clinicians often underrate functional and psychosocial issues in adult 
patients.16,17  Pediatricians have also been shown to underestimate emotional and behavioral 
problems in children, leading to the labeling of psychosocial issues in pediatric populations as a 
“hidden morbidity.”18  In pediatric clinical practice, good quality communication between 
patients and providers is critical since younger patients may lack the cognitive development and 
language skills necessary to verbally describe HRQOL issues.14   
    Measuring HRQOL in pediatric palliative care is uniquely complex as both serious 
illness- and pediatric-related conceptual and methodologic challenges must be addressed.  
Pediatric palliative care covers a wide variety of illnesses and conditions, many of which are 
rare.  Generic and disease-specific quality of life measures have been developed for seriously ill 
adults and healthy children but may not be suitable for a pediatric palliative care population. 
HRQOL measures for adults often include questions about activities that may not apply to 
children such as working, driving, housework, or the ability to perform self-care.  Additionally, 
HRQOL structures for a pediatric palliative care appropriate population may be different from 
those previously validated in a less ill population.  For example, the Pediatric Quality of Life 
Inventory (PedsQL) 4.0 has been shown to be a reliable and valid measure of HRQOL in a 
variety of diseases and conditions, including some life-limiting illnesses.  However, an attempt to 
validate the PedsQL in a generic pediatric palliative care population found that hypothesis testing 
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for construct validity was not supported which suggests that HRQOL factors for a pediatric 
palliative care population differ from both healthy and less severely ill populations.   
      Pediatric palliative care measures should also be responsive to various stages of language 
and cognitive development.  Additionally, seriously ill patients may become easily fatigued or 
may experience disease and/or treatment related cognitive limitations that require careful 
consideration of measure characteristics such as instrument length, response options and  recall 
periods.   
      While clinicians who utilize patient-reported HRQOL data with adult patients are more 
likely to appropriately diagnose and treat psychosocial and functional issues than their 
counterparts, less is known about how to implement this practice with children.19  The goal of 
this paper is to present a systematic review of outcome measures used to assess HRQOL in 
pediatric palliative care appropriate patients.   Previous reviews have been unable to recommend 
any HRQOL measurement tools suitable for broad use in pediatric palliative care.1,20  The aim of 
this systematic literature review is to examine and summarize the quality of the measurement 
properties of recent patient- and parent-reported HRQOL outcome measures for children and 
young people up to 18 years of age with serious illness.  Building upon the previous review of 
pediatric palliative care outcome measures conducted by Coombes et al. (2016) this review will 
explore recent HRQOL literature to identify new studies that evaluated the measurement 
properties of new or existing outcome measures in a pediatric palliative care appropriate 
population.1  The ultimate goal of this study is to improve the quality of life for children and 






Literature Search Strategy 
      A systematic review published by Coombes et al. in 2016 was the first review of HRQOL 
measures in pediatric palliative care but was unable to identify any high-quality outcome 
measures for use in this population1.  Prompted by the growth in the fields palliative medicine 
and patient-reported outcomes, this search aimed to improve upon the search previously 
conducted by Coombes et al. by bringing it up to date.1 EMBASE, Medline, and PsychInfo were 
searched from December 1st, 2014 to January 12th, 2020 in an effort to identify new instruments 
or new validation information for existing instruments.  Search terms included a combination of 
palliative care, supportive care, children, adolescents, outcomes, instruments, and related terms 
(see Appendix 1 for the full search strategy).  The results from each database were downloaded 
into EndNote ® [Thomson Reuters (Scientific) Inc., Carlsbad, CA, U.S.A.] and duplicates were 
removed.    
Inclusion and Exclusion Criteria 
      A publication was included if it was a full text, English language, peer-reviewed 
manuscript and met the following additional criteria:  
1. published between December 1st, 2014  – January 12th, 2020, 
2. the study sample included human infants, children, or young adults aged 0 – 18 years old,  
3. at least 25% of the study sample had to be living with a life-limiting, life-threatening, or 
complex chronic disease associated with high morbidity or mortality 4,  
4. examined at least once measurement property (e.g. reliability, validity, or responsiveness) 
of a patient- or parent-reported outcome measure, 
5. clinician-reported HRQOL outcome measures were excluded.  
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Study Selection and Methodological Quality Assessment Approach  
     The titles and abstracts of all identified publications were screened for the inclusion criteria. 
Full text of potentially eligible manuscripts was evaluated based on the previously specified 
inclusion and exclusion criteria.  Data was extracted on the characteristics of each included study 
and outcome measure, including information about the study sample, interpretability, and 
feasibility of using the measure in a pediatric palliative care population. 
      The methodological quality of each included manuscript was assessed using the 
COnsensus based Standards for the selection of health Measurement INstruments (COSMIN) 
Risk of Bias Checklist.21   The COSMIN checklist specifies nine measurement properties to 
evaluate:  
1. Content validity is a measure that the content of an instrument is an appropriate reflection 
of the construct to be measured.  All items should be comprehensible and relevant to the 
population of interest and comprehensive of the construct of interest.  Content validity 
should be assessed and agreed upon by subject matter experts.   
2. Structural validity is a measure of the degree to which scores are an adequate reflection 
of the dimensionality of the construct of interest.  Structural validity is often assessed 
using confirmatory factor analysis or item response theory.  A sufficient (+) rating is 
given if Comparative Fit Index or Tucker-Lewis Index are greater than 0.95 or the Root 
Mean Square Error of Approximation is less than 0.06.  
3. Internal consistency is a measure of homogeneity or interrelatedness among the items in 
the scale and subscales and is often assessed using factor analysis.  A sufficient (+) rating 
is given if (a) the sample size is greater than 100 and 7 times the number of items in the 
measure, and (b) Cronbach’s α is greater than 0.70.  
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4. Measurement invariance and cross-cultural validity are measures of important differences 
in how the outcome measure performs or is interpreted between cultural or other study 
groups (e.g., disease severity). Measurement invariance is often assessed using regression 
analysis or confirmatory factor analysis. A sufficient (+) rating is given if no important 
differences are found between groups in factor analysis or McFadden’s R2 is less than 
0.02.  
5. Reliability is a measure of the reproducibility of scores between administrations when 
measurement conditions remain stable.  Reliability measures consistency, not accuracy, 
and is often assessed by intraclass correlation coefficient or Kappa calculations. A 
sufficient (+) rating is achieved if (a) the sample size is 50 or more, and (b) an intraclass 
correlation coefficient or Kappa was 0.70 or higher for each domain.   
6. Measurement error is a measure of deviations of the score, or systematic random errors, 
that are not attributable to changes in the construct of interest.  Measurement error is 
often assessed using standard error of measurement, smallest detectable change, limits of 
agreement, or percent agreement calculations. A sufficient (+) rating is given if the 
smallest detectable change or limit of agreement are smaller than the minimum important 
change.  
7. Criterion validity is a measure of how well scores correlate with an existing gold 
standard. Criterion validity is rarely assessed for patient-reported outcome measures since 
there is seldom a gold standard measure available for comparison. A sufficient (+) rating 
is given if correlation with the gold standard is at least 0.70.  
8. Hypothesis testing for construct validity is a measure of the degree to which scores are 
consistent with a previously stated hypothesis.  Construct validity is often assessed using 
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known groups validity, i.e., comparison between subgroups, convergent and/or divergent 
validity, i.e., comparison with other instruments. A sufficient (+) rating is given if 75% of 
the pre-specified hypotheses are confirmed.  
9. Responsiveness is a measure of sensitivity to change or the ability to detect clinically 
important changes over time in the construct of interest.  Responsiveness is often 
assessed using effect size calculations.  A sufficient (+) rating is given if the area under 
the curve is at least 0.70 or the 75% of pre-specified hypothesis are confirmed.   
Each measurement property was assessed based on how it had been tested during the study and 
was given a rating of very good, adequate, doubtful, or inadequate.21,22  
Synthesis of Results  
Measurement property evaluations were pooled for each outcome measure and the 
quality of the evidence was graded using a modified Grading of Recommendations, Assessment, 
Development, and Evaluations (GRADE) approach and rated as high, moderate, low, or very 
low.22  Quality ratings were downgraded based on four GRADE factors: (1) risk of bias 
(inadequate quality studies), (2) inconsistency (conflicting results), (3) imprecision (small sample 
size) , and (4) indirectness (portion of study population is not the population or context of 
interest).  Study results of measurement property assessments were evaluated using the COSMIN 
criteria of good measurement properties and rated as sufficient (+), insufficient (-), or 
indeterminate (?).22,23     
Results  
A total of 1,401 unique manuscripts were identified and screened.  Figure 1 displays a 
flowchart describing the process and outcome of each stage of manuscript review and selection 
for inclusion according to the Preferred Reported Items for Systematic Reviews and Meta-
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Analysis (PRISMA) guidelines. After title and abstract screening and exclusion, 159 full text 
manuscripts were assessed for eligibility.  Common reasons for exclusion included studies of 
non-HRQOL outcomes (e.g., physical symptoms only or utility measures), adult or not palliative 
care appropriate sample populations (e.g., obesity or scoliosis), and studies that did not evaluate 
measurement properties (e.g., studies of treatment effects or concept development).  After full 
text exclusion, 19 manuscripts of 18 studies were included that evaluated the measurement 
properties of 12 patient- or parent-reported HRQOL measures tested in pediatric palliative care 
appropriate populations.  Two manuscripts presented results of the same study and were 
analyzed together. All further analyses presented here are based on these final 18 studies. 
Description of Studies  
       An overview of the key characteristics of the 18 included studies is presented in Table 1. 
The study characteristics described are: authorship, publication year, name of patient- or parent-
reported outcome measure, age range of patients included in study, if the measure was self 
Figure 1. PRISMA flow diagram 
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and/or parent reported, the potentially palliative care appropriate population, and the number of 
study participants. No studies of outcome measures for use specifically in specialty pediatric 
palliative care were identified.  Instead, all of the included studies were conducted with a 
pediatric palliative care appropriate sample population of children and young people with a life-
limiting or life-threatening illness.  Epilepsy (six studies), cancer (three studies), and sickle cell 
disease (three studies) were the most common serious illnesses studied.  Only five of the 18 
studies evaluated both patient- and parent- reported outcome measures with all five representing 
a version of the Pediatric Quality of Life Inventory (PedsQL).24-28  Of the remaining studies 
seven used only patient-reported measures and six used only parent-reported measures.  The 
majority of the studies had sample sizes larger than 100 participants (13/18) with a range of 20 – 
2694 participants.   
Description of Outcome Measures  
      The 12 patient- and parent- reported HRQOL outcome measures included were the 
Experience Sampling (ESM) Diary29, the Modified Parent Cystic Fibrosis Questionnaire—
Revised (mParent CFQ-R)30, the Neurology Quality of Life Measurement System (Neuro-
QoL)31, the Niemann‑Pick type C quality-of-life questionnaires for children (NPCQLQ-C)32, 
four versions of the PedsQL: (1) Generic Core Scales (PedsQL GCS)25,27, (2) PedsQL Epilepsy28 
(3) Neuromuscular Module (PedsQL NMM)24, (4) Sickle Cell Disease (PedsQL SCD)26, the 
Patient Reported Outcomes Measurement Information System (PROMIS)33-36, the QoL survey 
for people with disability37, and two versions of the Quality of Life in Childhood Epilepsy 
Questionnaire: QOLCE-5538-40 and QOLCE-1641,42.  An overview of the key characteristics of 
included patient- and parent- reported outcome measures, including measure name, if it is a 
generic, i.e., applicable to numerous diseases or conditions, or disease-specific oriented measure, 
11 
 
the number of HRQOL domains or subscales being measured, number of items or questions in 
the measure, recall or look back period, response options, and potential range of scale scores are 
displayed in Table 2.   
      The majority of the measures were disease-specific, with only two generic, Peds QL GCS 
and PROMIS, and ten disease-specific measures identified.  None of the measures were 
developed for, or validated in, a pediatric population receiving palliative care. Of the disease-
specific measures, three were designed for use in children and young people with epilepsy 
(PedsQL Epilepsy, QOLCE-55, and QOLCE-16), one for cystic fibrosis (mParent CFQ-R), one 
for significant disability (QoL survey for people with disability), one for Duchenne Muscular 
Dystrophy (ESM), one for neurological disorders (Neuro-QoL), one for neuromuscular disorders 
(PedsQL NMM), one for Niemann‑Pick Type C (NPCQLQ-C), and one for sickle cell disease 
(PedsQL SCD). Recall time was no longer than one month for any measure with five measures 
using one week/seven days, four measures using one month/four weeks, two measures using a 
combination of recall periods depending on the item, and one measure using time of 
administration.  All but one of the included measures utilized 4- or 5-point Likert scale response 
options with the remaining measure utilizing a 100-point visual analogue scale (VAS).29,43 
Number of items ranged from 15 – 107.  
Methodological Quality of Included Measures  
      Of the nine measurement properties outlined in COSMIN risk of bias checklist, content 
validity, criterion validity, and measurement error were not assessed by any of the identified 
studies and were therefore not included in the tables.  As criterion validity is a measure of how 
well an instrument’s scores reflect the gold standard, the absence of criterion validity analysis 
was expected since outcome measures typically do not have a gold standard.21,22  Cross-cultural  
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Abbreviations: ESM: Experience Sampling; mParent CFQ-R : Modified Parent Cystic Fibrosis Questionnaire—Revised; Neuro-QoL: Neurology 
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Table 1: Characteristics of included studies  
Author Year Measure Age 
Range 
Report  Palliative Care 
Appropriate Population 
n 
Alpern et al30 2015 mParent CFQ-
R 
4 mo – 
5 years 





2-18 Parent  Critically ill and admitted to 
PICU or CICU (50% with 
Complex Chronic Disease) 
367 
5-18 Self 
PedsQL Infant 1-24 
months Parent  
Aston et al32 2019 NPCQLQ-C 0-17  Parent  Niemann‑Pick Type C 23  





2017 QOLCE-55 4-18 Parent  Epilepsy 136 
Dampier et 
al33 
2016 PROMIS 8-17 Self Sickle Cell Disease 235 
Deroche et 
al37 
2015 QoL survey 
for people 
with disability 
15-24 Self Fragile X, Spina Bifida, and 
Muscular Dystrophy 
174 
Desai et al27 2014 PedsQL4.0 
GCS 
2-18 Parent  Admitted to medical or 
surgical unit of the hospital;  
no chronic illness, 
noncomplex chronic illness, 
and complex critical illness  
2694 
13-18 Self 
PedsQL Infant 1-24 
months 
Parent  
Ferro et al39 2016 QOLCE-55 4-12 Parent  Epilepsy 373 
Goodwin et 
al40 





QOLCE-16 4-12 Parent  Epilepsy 373 
Hinds et al34 2019 PROMIS 8-18 Self Cancer 96 
Hinds et al35 2017 PROMIS 8-17 Self Cancer 20 





16† Self & 
Parent  
Duchenne muscular dystrophy 278 









2017 PedsQL SCD 4-21 Self & 
Parent  
Sickle Cell Disease 187 
Reeve et al 2018 PROMIS 8-17 Self Cancer, nephrotic syndrome, 




validity was also not assessed, but its partner measurement invariance was reported in five 
studies and included in the tables. Table 3 gives an overview of the methodological quality of 
identified outcome measures by study.  Missing items indicate that the measurement property 
was not evaluated by the study.  
The methodological quality ratings and associated level of evidence quality of each of the 
included studies by measurement property were pooled for each patient- and parent-reported 
HRQOL outcome measure.  The synthesis of the results for structural validity, internal 
consistency, and measurement invariance are shown in Table 4 and reliability, hypothesis testing 
for construct validity, and responsiveness are shown in Table 5. 
      Quality scores for the remaining six measurement properties ranged from very good to 
inadequate.  Internal consistency was one of the most frequently assessed measurement 
properties and was reported in 11 of the 18 studies.  However, 73% of these studies failed to 
report if the scale or subscale was unidimensional leading to a score of “doubtful” 
methodological quality.  Hypothesis testing for construct validity was also assessed in 11 studies, 
all of which received acceptable scores of either very good (73%) and adequate (27%).    
      Structural validity was tested using appropriate methods of confirmatory or exploratory 
factor analysis in six of seven studies.  The one study that received an inadequate score had a 
sample size of less than 100 which was not large enough to support the Rasch analysis 
performed.   Measurement invariance and responsiveness were both evaluated in 5 studies.  
Reliability was only evaluated in three studies. 
 
 














ESM Diary  Specific 2 (internal and contextual 
dimensions of experience)  
19 Now 100-point VAS 0 – 100 
mParent 
CFQ-R 
Specific 5 (respiratory symptoms, 
treatment burden, vitality, 
health perceptions, physical 
functioning)  
26 Past week 4-point Likert 
scale 
0-100 
Neuro-QoL Specific 9 (social relations, 
cognitive function, 
depression, anxiety, stigma, 
fatigue, pain, upper and 
lower extremity function) 
107 Past 7 days 5-point Likert 
scale from 1 (not 
at all) to 5 (very 
much)  
0-100  
NPCQLQ-C Specific 6  (embodiment, identity, 
intersubjectivity, mood, 
spatiality, temporality) 
15 Past 4 
weeks 
5-point Likert 
from 1 (never) to 
5 (always)  
15 - 75 
PROMIS Generic  5 general domains 
(physical function, pain, 
fatigue, emotional health, 
and social health) 
97-107 Past 7 days 5-point Likert 
from never to 



























from 0 (never a 
problem) to 4 





Specific 5 (impact, cognitive, Sleep, 
executive functioning, and 
mood/behavior) 
29 Past month 5-point Likert 
from 0 (never a 
problem) to 4 





Specific 3 (about neuromuscular 
disease, communication, 
family resources)  
25 Past month 5-point Likert 
from 0 (never a 
problem) to 4 





Specific 9 (pain and hurt, pain 
impact, pain management, 
worry (I & II), emotions, 
treatment, communication 
(I & II) 
43 Past month 5-point Likert 
from 0 (never a 
problem) to 4 
(almost always a 
problem) 
0-100 
       
  
        Table 2. Characteristics of the identified PROMs  
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Table 2. (Continued) 
Measure 
Generic/ 









QOLCE-55 Specific 4 (cognitive functioning, 
emotional functioning, social 
functioning, physical 
functioning)  
55 Past week 5-point Likert 
from 0 (very 
often) to 4 
(never) 
0-100 
QOLCE-16 Specific 4 (cognitive functioning, 
emotional functioning, social 
functioning, physical 
functioning) 
16 Past week 5-point Likert 
from 0 (very 







Specific 5 (emotional health, physical 
health, independence, activity 
limitations, community 
participation)   
20 Past 
month and 




Abbreviations: ESM: Experience Sampling; mParent CFQ-R : Modified Parent Cystic Fibrosis Questionnaire—Revised; Neuro-QoL: Neurology 
Quality of Life Measurement System; NPCQLQ-C:  Niemann‑Pick type C quality-of-life questionnaires for children; PedsQL: Pediatric Quality 
of Life Inventory - GCS: Generic Core Scales, NMM: Neuromuscular Module, SCD: Sickle Cell Disease; PROMIS: Patient Reported Outcomes 
Measurement Information System; QOLCE: Quality of Life in Childhood Epilepsy Questionnaire 
 
Discussion 
      The aim of this systematic literature review was to describe and evaluate the 
methodological quality of recent patient- and parent-reported HRQOL outcome measures for 
pediatric palliative care appropriate patients. A systematic review published by Coombes et al. in 
2016 was the first review of HRQOL measures in pediatric palliative care but was unable to 
identify any high-quality outcome measures for use this population.1   The review summarized 
here identified 18 studies of 12 outcome measures published after the seminal Coombes et al 
systematic review.1 Summaries of the findings from this review are presented in Tables 3-5. 
Methodologic Quality of Pediatric Measures  
      Psychometric evidence was limited, and methodologic quality varied among all of the 
identified measures.  Internal consistency and hypothesis testing were the most commonly 
assessed measurement properties.  The PedsQL NMM and QOLCE-16 were the only measures 
to have both internal consistency and unidimensional reported. Internal consistency assessments 
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for the remaining measures should be viewed with caution since it is unknown if the scale is a 
unidimensional measure of HRQOL as a construct.  
Measure 











ESM Diary       
   Bray et al29 Inadequate Very Good  Inadequate   
mParent CFQ-R       
   Alpern et al30  Doubtful  Adequate   Adequate   
Neuro-QoL       
   Lai et al31  Doubtful   Adequate  
NPCQLQ-C       
   Aston et al32    Doubtful     Very good   
PedsQL 4.0 
GCS 
      
   Aspesberro  
    et al25 
    Very Good  Adequate 
   Desai et al27     Very Good Very Good 
PedsQL 
Epilepsy 
      
   Modi et al28 Very Good  Doubtful Very Good Very Good Very Good  
PedsQL NMM       
   Landfeldt et 
al24 
Very Good  Very Good      
PedsQL SCD       
   Panepinto et 
al26 
     Very Good 
PROMIS       
   Dampier et al33     Very Good  
   Hinds et al34  Doubtful   Adequate Doubtful  
   Hinds et al35  Doubtful     
   Reeve et al36      Very Good 
QOLCE-55       
   Conway et al38 Adequate Doubtful Doubtful Adequate  Very Good  
   Ferro et al39   Adequate     
   Goodwin et al40 Very Good Doubtful   Very Good  
QOLCE-16       
   Goodwin  
    et al41,42 
Very Good Very Good Adequate    
QoL survey for people with disability     
   Deroche et al37 Adequate    Very Good  
Abbreviations: ESM: Experience Sampling; mParent CFQ-R : Modified Parent Cystic Fibrosis Questionnaire—Revised; Neuro-QoL: Neurology 
Quality of Life Measurement System; NPCQLQ-C:  Niemann‑Pick type C quality-of-life questionnaires for children; PedsQL: Pediatric Quality 
of Life Inventory - GCS: Generic Core Scales, NMM: Neuromuscular Module, SCD: Sickle Cell Disease; PROMIS: Patient Reported Outcomes 
Measurement Information System; QOLCE: Quality of Life in Childhood Epilepsy Questionnaire 
 
  
 Table 3: Methodological quality of identified outcome measures by study 
17 
 
Measure Structural Validity Internal Consistency 
Measurement 
Invariance 
 Rating Quality Rating Quality Rating Quality 
ESM Diary - Low ? Low  + Low 
mParent CFQ-R   ? Low + Moderate 
Neuro-QoL   ? Low   
NPCQLQ-C   ? Low   
PedsQL GCS       
PedsQL Epilepsy + High ? Low + High 
PedsQL NMM - Moderate + Moderate    
PedsQL SCD       
PROMIS   ? Low   
QOLCE-55 + Moderate ? Low ? Moderate 
QOLCE-16 + Moderate + Moderate + Moderate 




    
Abbreviations: ESM: Experience Sampling; mParent CFQ-R : Modified Parent Cystic Fibrosis Questionnaire—Revised; Neuro-QoL: Neurology 
Quality of Life Measurement System; NPCQLQ-C:  Niemann‑Pick type C quality-of-life questionnaires for children; PedsQL: Pediatric Quality 
of Life Inventory - GCS Generic Core Scales, NMM: Neuromuscular Module, SCD: Sickle Cell Disease; PROMIS: Patient Reported Outcomes 
Measurement Information System; QOLCE: Quality of Life in Childhood Epilepsy Questionnaire 
 
Measure Reliability Hypothesis Testing        Responsiveness 
 Rating Quality Rating Quality Rating Quality 
ESM Diary + Low     
mParent CFQ-R   + Moderate   
Neuro-QoL   ? Moderate   
NPCQLQ-C   + Low   
PedsQL 4.0 GCS   + Moderate + Moderate 
PedsQL Epilepsy + High + High   
PedsQL NMM       
PedsQL SCD     + Moderate  
PROMIS   + Moderate + Low 
QOLCE-55 + Moderate ? Moderate    
QOLCE-16       
QoL survey for 
people with 
disability 
  + Moderate   
Abbreviations: ESM: Experience Sampling; mParent CFQ-R : Modified Parent Cystic Fibrosis Questionnaire—Revised; Neuro-QoL: Neurology 
Quality of Life Measurement System; NPCQLQ-C:  Niemann‑Pick type C quality-of-life questionnaires for children; PedsQL: Pediatric Quality 
of Life Inventory - GCS: Generic Core Scales, NMM: Neuromuscular Module, SCD: Sickle Cell Disease; PROMIS: Patient Reported Outcomes 
Measurement Information System; QOLCE: Quality of Life in Childhood Epilepsy Questionnaire 
 
  
Table 4: Data synthesis: Internal Validity 
Table 5: Data Synthesis: Other Measurement Properties 
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       Responsiveness was only reported in three of the 12 measures: PedsQL GCS, PedsQL 
SCD, and PROMIS. Children and young people with life-limiting or life-threatening illness often 
experience frequent symptom and functional status changes that can significantly impact their 
HRQOL.  Since improving quality of life is one of the primary goals of palliative care, it is 
especially important that pediatric palliative care appropriate measures of HRQOL are 
responsive to change.  Measurement error was not assessed or reported for any of the HRQOL 
measures therefore instrument scores should be viewed with caution since the amount of 
systematic random error is unknown.   
      The PedsQL GSC and PROMIS measures have been tested in several life-limiting illness 
populations and both had sufficient methodological quality with moderate evidence for 
hypothesis testing of construct validity and moderate to low evidence, respectively, for 
responsiveness to change.  However, little is known about the internal validity of these measures 
and future testing of structural validity, internal consistency, and measurement invariance would 
provide greater insight into the psychometric quality of these instruments.  
     PedsQL Epilepsy and QOLCE-55 had the highest methodologic quality overall, although 
given the high number of items, the QOLCE-55 might prove burdensome for children and their 
parents to complete.  The QOLCE-16 shows promise as shorter measure of HRQOL in epilepsy 
but may require additional psychometric testing before use. 
Measurement Considerations and Research Implications  
Generic vs. Disease Specific Measures 
      Pediatric palliative care covers a wide variety of illnesses and conditions.  While all of 
the included HRQOL measures were tested on a sample with potentially palliative care 
appropriate diseases, none have been validated in children and young people who actually 
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received palliative care services.  Studies of children with chronic illnesses or disabilities 
reported lower HRQOL than their healthier peers, however the effect size varied by health 
condition and domain(s) assessed.44,45  This variation supports the need for a generic serious 
illness HRQOL measure that is able to be used across conditions enabling use in a heterogenous 
palliative care population.   
      Only two of the 12 measures identified in this review were generic measures of HRQOL 
– PedsQL GCS and PROMIS.  A previous study outside the scope of this review attempted to 
validate the PedsQL in a life-limiting illness population but found that the measure lacked the 
psychometric properties needed to accurately measure HRQOL in a pediatric palliative care 
population.46 Huang et al evaluated the validity and reliability of the PedsQL in a sample of 
children and young people with a life-limiting illness who met the criteria for an integrated 
pediatric palliative care hospital admission and a comparison group of children enrolled in 
Medicaid.  Confirmatory factor analysis implied an unacceptable model fit for a serious illness 
population 5 to 18 years of age with a comparative fit index of 0.69 (CFI > 0.9 satisfactory) and 
root mean square error of approximation of 0.25 (RMSEA < 0.06 satisfactory).46  Therefore, 
construct validity was not supported by confirmatory factor analysis which could suggest that 
HRQOL factors for children and young people with serious, life-limiting illness and healthier 
populations may be different further exemplifying the need for a life-limiting illness specific 
HRQOL measure.  Additionally, children with less serious conditions were not more likely to 
report higher HRQOL than those with more serious conditions.  This contradicts the both the 
hypnotized relationship and existing literature on pediatric HRQOL that demonstrates lower 
HRQOL and higher physical, functional, psychological, and social burden for seriously ill 
children and young people.46-48 
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      PROMIS measures of HRQOL were tested in sickle cell disease, nephrotic syndromes, 
and cancer populations and while more testing is needed, show potential for use in a broader 
pediatric palliative care population.   
      Disease-specific HRQOL measures are only relevant for the condition of interest and 
cannot be used to compare HRQOL across illness groups.  Furthermore, pediatric palliative care 
clinicians would have to be aware of, and have access to, a multitude of disease-specific 
instruments in order to assess HRQOL for all of their patients, which is not feasible.  The factors 
contributing to HRQOL in this seriously ill and heterogeneous population should also be 
explored.   
Validation across age ranges 
      Reviews of younger children’s ability to self-report pain and other physical symptoms 
have indicated a lack of evidence for children less than five years of age being able to accurately 
use self-report tools.49  Another review of self-reported symptom instruments in children with 
cancer determined that current instruments were not reliable or valid in children younger than 
8.50  Of the studies identified in this review, the PedsQL GCS and PedsQL Epilepsy utilized self-
report starting at five years of age, while the remaining studies started at eight years of age or 
older.  
      There is also evidence that younger children, 5 to 7 years of age, have trouble interpreting 
the more nuanced intermediate scores in 5-point Likert style scales and instead typically select 
the extreme or middle responses while children 8 years of age and older are able to fully 
understand a 5-point range.51  This finding suggests that response options should be tailored to 
age, with younger children receiving less options.  Further study should be conducted in children 
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with life-limiting illness to explore if illness burden plays a role in ability to understand response 
options. 
Patient and proxy reported measures  
      HRQOL is an individually subjective construct and is best represented through patient 
report when possible.52  Studies have shown a lower correlation between parents and children for 
non-observable constructs, like quality of life and emotional problems, and higher correlations 
for observable constructs, such as physical aspects.1,52 Children may have a different 
understanding of HRQOL than their older parents, and parents may not be privy to a child’s 
social interactions or aware of psychosocial issues.52  HRQOL measures for use in pediatric 
palliative care populations should be available in both patient- and proxy-reported versions. 
Limitations 
      This search was limited to three databases and restricted to English language peer-
reviewed manuscripts.  This could exclude studies of outcome measures in other languages that 
are relevant to a pediatric palliative care population.  Due to project constraints this literature 
review was conducted by one reviewer.  Additional reviewers are needed to increase the 
reliability of the results.   
Conclusion  
      This review identified 18 studies of 12 HRQOL patient- and parent-reported outcome 
measures for children and young people with serious illness. Psychometric evidence was limited, 
and methodologic quality varied among all of the identified measures. Internal consistency and 
hypothesis testing for construct validity were most commonly assessed.  Information on 
measurement error, content validity, and criterion validity were not available for any instrument.  
No one instrument was identified as being appropriate for use in a non-disease specific pediatric 
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palliative care population.  The PedsQL Epilepsy and QOLCE-55 showed promise for use in 
children with epilepsy and palliative care needs.   
Future Directions 
      Patient-reported outcome and experience measures are needed to assess and provide 
quality care for children and young people with life-limiting illnesses.  Generic measures that 
capture the daily burdens of living with life-limiting illness are needed to compare HRQOL 
across a variety of diseases and conditions.  Given the heterogeneity of a pediatric palliative care 
population, developing a generic patient-reported HRQOL measure could be difficult because all 
items may not be relevant to all children.  A potential solution to this problem is to utilize 
individual items validated through item response theory (IRT) administered with content-
balanced computerized adaptive testing (CAT) instead of static models.  If properly assessed and 
employed, CAT administration may better assess HRQOL in a diverse serious illness population 
and could lead to reduced respondent burden.53 
      Additional solutions that may lead to improvements in the future include the development 
of new outcome measures, modification of existing measures to better assess HRQOL in 
pediatric palliative care, and additional field testing and cross-cultural validation of the African 
Palliative Care Association Children’s Palliative Outcome Scale (APCA c-POS), The APCA c-
POS is a PROM specifically developed to assess HRQOL in pediatric palliative care populations.  
However, the APCA c-POS was not included in the measure review because an English 
language version has not been developed and validated.20,54      
Leadership  
      Public health leadership skills, such as agenda setting, advocacy, and policy promotion, 
are needed to accelerate the development and implementation of pediatric palliative care 
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HRQOL measures.  Strong leadership skills are needed to identify and cultivate relationships 
with key stakeholders at all levels.  Palliative care and pediatric coalitions can be leveraged to 
advocate for the need for methodologically sound outcome measures and to promote policies that 
allocate funding for instrument development or validation in pediatric palliative care.  Leaders in 
the field can be utilized to set the research agenda to include rigorous psychometric testing of 
pediatric palliative care measures and to promote including validation of HRQOL instruments as 





APPENDIX: DETAILED SEARCH STRATEGY 
Database Strategy Results 
Medline Search ((((((((patient reported outcomes[Title/Abstract]) OR quality of 
life[Title/Abstract]) OR health status[Title/Abstract]) OR global 
health[Title/Abstract]) OR health related quality of 
life[Title/Abstract]) OR outcome measurement[Title/Abstract])) AND 
((((((((((((classical test theory[Title/Abstract]) OR 
validity[Title/Abstract]) OR reliability[Title/Abstract]) OR content 
validity[Title/Abstract]) OR confirmatory factor 
analysis[Title/Abstract]) OR exploratory factor 
analysis[Title/Abstract]) OR internal consistency[Title/Abstract]) OR 
test-retest[Title/Abstract]) OR psychometr*[Title/Abstract]) OR 
known group[Title/Abstract]) OR Rasch[Title/Abstract]) OR 
DIF[Title/Abstract])) AND (((((child*[Title/Abstract]) OR 
neonat*[Title/Abstract]) OR adolescent*[Title/Abstract]) OR 
pediatric*[Title/Abstract]) OR paediatric*[Title/Abstract]) AND ( 
"2014/12/01"[PDat] : "2020/01/12"[PDat] ) AND Humans[Mesh] 
AND English[lang] AND (infant[MeSH] OR child[MeSH] OR 
adolescent[MeSH]) 
689 
EMBASE ('patient-reported outcome':ab,ti OR 'quality of life':ab,ti OR 'health 
status':ab,ti OR 'global health':ab,ti OR 'outcome assessment':ab,ti) 
AND ('classical test theory':ab,ti OR validity:ab,ti OR reliability:ab,ti 
OR 'content validity':ab,ti OR 'confirmatory factor analysis':ab,ti OR 
'exploratory factor analysis':ab,ti OR 'internal consistency':ab,ti OR 
'test retest reliability':ab,ti OR psychometry:ab,ti OR 'known group 
validity':ab,ti OR 'rasch analysis':ab,ti) AND (child:ab,ti OR 
newborn:ab,ti OR adolescent:ab,ti OR pediatrics:ab,ti) AND 
[english]/lim AND ([newborn]/lim OR [infant]/lim OR [child]/lim OR 
[preschool]/lim OR [school]/lim OR [adolescent]/lim OR [young 
adult]/lim) AND [humans]/lim AND [2014-2020]/py 
533 
PsychInfo ((patient reported outcomes OR ( quality of life or well being or well-
being or health-related quality of life ) OR health status OR global 
health OR ( outcome measure or outcome tool or outcome assessment 
)) AND (classical test theory OR ( validity or reliability ) OR content 
validity OR confirmatory factor analysis OR exploratory factor 
analysis OR internal consistency OR test-retest OR psychometric OR 
known group OR rasch) AND (child or children or paediatric or 
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